Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
In silico design and immunoinformatics analysis of a chimeric vaccine construct based on Salmonella pathogenesis factors — Mohammad Hassan Jafari Najaf Abadi (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
In silico design and immunoinformatics analysis of a chimeric vaccine construct based on Salmonella pathogenesis factors
Shared by
Michael R Hamblin
In silico design and immunoinformatics analysis of a chimeric vaccine construct based on Salmonella pathogenesis factors
Article
2023
en
Authors
+8 more
MA
Mohammad Hassan Jafari Najaf Abadi
FA
Fahimeh Abdi Abyaneh
NZ
Noushid Zare
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
A rapid and convenient variant of fusion-PCR to construct chimeric flaviviruses
Nathalie Charlier
,
Richard Molenkamp
,
Pieter Leyssen
,
Anne‐Mieke Vandamme
,
De Clercq Erik
,
Peter J. Bredenbeek
,
Johan Neyts
Article
2022
A designed peptide-based vaccine to combat Brucella melitensis, B. suis and B. abortus: Harnessing an epitope mapping and immunoinformatics approach
Hossein Tarrahimofrad
,
Javad Zamani
,
Michael R Hamblin
,
Maryam Darvish
,
Hamed Mirzaei
Article
2022
Efficacy of Multivalent, Cochleate-Based Vaccine against Salmonella Infantis, S. Enteritidis and S. Typhimurium in Laying Hens
Leonardo Saénz
,
Miguel Guzmán
,
Sonia Vidal
,
Mario Caruffo
,
Daniela Siel
,
Caridad Zayas
,
Rodolfo Paredes
,
Carolina Valenzuela
,
Héctor Hidalgo
,
Óliver Pérez
,
Lisette Lapierre
Article
2019
In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18
Noor Rahman
,
Ijaz Muhammad
,
Gul E Nayab
,
Haroon Khan
,
Rosanna Filosa
,
Jianbo Xiao
,
Sherif T. S. Hassan
Article
2022
Defining “happy” in happy birthday: Singing accuracy a construct based on range and intervals
Bryan E. Nichols
,
Alex Hua
,
Zhong Lin Wang
Discussion(0)
No comments yet. Be the first to comment.